Let’s start up with the current stock price of Chembio Diagnostics Inc. (CEMI), which is $2.06 to be very precise. The Stock rose vividly during the last session to $2.4074 after opening rate of $2.39 while the lowest price it went was recorded $2.06 before closing at $2.46.
Recently in News on May 6, 2021, Chembio Diagnostics Reports First Quarter 2021 Financial Results. Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended March 31, 2021. Chembio achieved first quarter 2021 total revenue of $8.7 million and product revenue of $4.0 million, representing growth of 27% and a decline of 30%, respectively, compared to the prior year period. You can read further details here
Chembio Diagnostics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $8.75 on 01/26/21, with the lowest value was $2.06 for the same time period, recorded on 07/20/21.
Chembio Diagnostics Inc. (CEMI) full year performance was -58.30%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Chembio Diagnostics Inc. shares are logging -76.46% during the 52-week period from high price, and -13.45% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.38 and $8.75.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1386339 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Chembio Diagnostics Inc. (CEMI) recorded performance in the market was -56.63%, having the revenues showcasing -43.25% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 42.23M, as it employees total of 355 workers.
Chembio Diagnostics Inc. (CEMI) in the eye of market guru’s
During the last month, 1 analysts gave the Chembio Diagnostics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.58, with a change in the price was noted -3.59. In a similar fashion, Chembio Diagnostics Inc. posted a movement of -63.54% for the period of last 100 days, recording 3,458,502 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CEMI is recording 0.80 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.79.
Chembio Diagnostics Inc. (CEMI): Stocks Technical analysis and Trends
Raw Stochastic average of Chembio Diagnostics Inc. in the period of last 50 days is set at 0.00%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 0.00%. In the last 20 days, the company’s Stochastic %K was 6.51% and its Stochastic %D was recorded 5.63%.
If we look into the earlier routines of Chembio Diagnostics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -56.63%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -64.30%, alongside a downfall of -58.30% for the period of the last 12 months. The shares increased approximately by -20.77% in the 7-day charts and went up by -32.01% in the period of the last 30 days. Common stock shares were lifted by -43.25% during last recorded quarter.